This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1994 Jul;27(1):1-5.

doi: 10.2165/00003088-199427010-00001.

Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences

K T Kivistö¹, P J Neuvonen, U Klotz

Affiliations

PMID: 7955768
DOI: 10.2165/00003088-199427010-00001

Review

Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences

K T Kivistö et al. Clin Pharmacokinet. 1994 Jul.

. 1994 Jul;27(1):1-5.

doi: 10.2165/00003088-199427010-00001.

Authors

K T Kivistö¹, P J Neuvonen, U Klotz

Affiliation

¹ Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.

PMID: 7955768
DOI: 10.2165/00003088-199427010-00001

No abstract available

PubMed Disclaimer

Similar articles

Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals.
Jurima-Romet M, Crawford K, Cyr T, Inaba T. Jurima-Romet M, et al. Drug Metab Dispos. 1994 Nov-Dec;22(6):849-57. Drug Metab Dispos. 1994. PMID: 7895601
Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
Venkateswarlu K, Denning DW, Kelly SL. Venkateswarlu K, et al. J Med Vet Mycol. 1997 Jan-Feb;35(1):19-25. J Med Vet Mycol. 1997. PMID: 9061581
Applications of primary human hepatocytes in the evaluation of pharmacokinetic drug-drug interactions: evaluation of model drugs terfenadine and rifampin.
Li AP, Jurima-Romet M. Li AP, et al. Cell Biol Toxicol. 1997 Jul;13(4-5):365-74. doi: 10.1023/a:1007451911843. Cell Biol Toxicol. 1997. PMID: 9298257
[Treatment with terfenadine and ketoconazole or itraconazole can cause torsades de pointes ventricular tachycardia].
Pohjola-Sintonen S. Pohjola-Sintonen S. Duodecim. 1993;109(2):164-6. Duodecim. 1993. PMID: 8013320 Review. Finnish. No abstract available.
Ketoconazole and fluconazole drug interactions.
Baciewicz AM, Baciewicz FA Jr. Baciewicz AM, et al. Arch Intern Med. 1993 Sep 13;153(17):1970-6. Arch Intern Med. 1993. PMID: 8357281 Review.

See all similar articles

Cited by

Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.
Haria M, Bryson HM, Goa KL. Haria M, et al. Drugs. 1996 Apr;51(4):585-620. doi: 10.2165/00003495-199651040-00006. Drugs. 1996. PMID: 8706596 Review.
Antibiotic exposure and its relationship to postantibiotic effect and bactericidal activity: constant versus exponentially decreasing tobramycin concentrations against Pseudomonas aeruginosa.
Li RC, Zhu ZY, Lee SW, Raymond K, Ling JM, Cheng AF. Li RC, et al. Antimicrob Agents Chemother. 1997 Aug;41(8):1808-11. doi: 10.1128/AAC.41.8.1808. Antimicrob Agents Chemother. 1997. PMID: 9257767 Free PMC article.
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Carpenter LL, McDougle CJ, Epperson CN, Price LH. Carpenter LL, et al. Drug Saf. 1996 Aug;15(2):116-34. doi: 10.2165/00002018-199615020-00004. Drug Saf. 1996. PMID: 8884163 Review.
The use of other drugs to allow a lower dosage of cyclosporin to be used. Therapeutic and pharmacoeconomic considerations.
Jones TE. Jones TE. Clin Pharmacokinet. 1997 May;32(5):357-67. doi: 10.2165/00003088-199732050-00002. Clin Pharmacokinet. 1997. PMID: 9160170 Review.
Hepatic disposition of fexofenadine: influence of the transport inhibitors erythromycin and dibromosulphothalein.
Milne RW, Larsen LA, Jørgensen KL, Bastlund J, Stretch GR, Evans AM. Milne RW, et al. Pharm Res. 2000 Dec;17(12):1511-5. doi: 10.1023/a:1007609225851. Pharm Res. 2000. PMID: 11303961

See all "Cited by" articles

References

1. JAMA. 1993 Mar 24-31;269(12):1532-6 - PubMed
1. JAMA. 1991 Nov 6;266(17):2375-6 - PubMed
1. Br J Clin Pharmacol. 1989 Aug;28(2):166-70 - PubMed
1. Lancet. 1991 Feb 2;337(8736):268-9 - PubMed
1. Carcinogenesis. 1990 Dec;11(12):2275-9 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer